Holly Schachner, M.D., is the Chief Medical Officer, Deerfield Management and joined the Firm in 2023. Prior to Deerfield, Dr. Schachner was the Head of Clinical Development at North Sea Therapeutics, B.V. and she was the Chief Medical Officer at Double Rainbow Biosciences. Before these roles, she was the Senior Vice President, Clinical Development and Therapeutic Area and Innovative Trial Design Head for Myokardia-BMS and the Chief Medical Officer, Global Specialty Medicine for Allergan. Dr. Schachner also spent five years at Sanofi in various roles of increasing leadership, six years at Bayer Diabetes Care as Senior Director, Head of Global Medical Affairs, and five years at Pfizer. Prior to industry, Dr. Schachner received her training in pediatric endocrinology at Mount Sinai and led the Pediatric Diabetes program at Columbia University. She holds a B.A. in Psychology from the University Of Michigan and an M.D. from SUNY at Stony Brook School of Medicine.